UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_____________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): July 20, 2016

STRATA SKIN SCIENCES, INC.

(Exact Name of Registrant Specified in Charter)

 

 

 

 

 

Registrant's telephone number, including area code:   215-619-3200

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     ☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     ☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     ☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     ☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 1.01.

Entry into a Material Definitive Agreement.

On July 20, 2016, we entered into extension agreements to existing consulting agreements dated November 4, 2015 with two of our directors, Jeffrey F. O'Donnell, Sr. and Samuel E. Navarro.  The amendments extended the termination dates of two consulting agreements from June 30, 3016 to September 30, 2016.  The other terms of the agreements remain unmodified.

Item 9.01.

Financial Statements and Exhibits.

 

Exhibit No.

Exhibit Description

10.1	Extension Agreement dated as of July 20, 2016 between Strata Skin Sciences, Inc. and Jeffrey F. O'Donnell, Sr.

10.2	Extension Agreement dated as of July 20, 2016 between Strata Skin Sciences, Inc. and Samuel E. Navarro.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:  July 22, 2016

 

 

 

---

EXTENSION AGREEMENT

EXTENSION AGREEMENT dated as of July 20, 2016 between Strata Skin Sciences, Inc. (the "Company"), a Delaware corporation, and Jeffrey F. O'Donnell, Sr. (the "Consultant") effective as of July 1, 2016 (the "Effective Date").

Recitals:

The parties entered into a Consulting Agreement dated as of November 4, 2015 (the "Agreement"), under which the Consultant provided consulting services to the Company.  The Consulting Agreement continued in effect through June 30, 2016.  The parties wish to extend the term of the Agreement through September 30, 2016, as provided in this Amendment.

NOW, THEREFORE, in consideration of the premises and covenants set forth herein, and intending to be legally bound hereby, the parties agree as follows:

IN WITNESS WHEREOF, the parties have caused this Amendment to be executed as of the date first written above.

---

EXTENSION AGREEMENT dated as of July 20, 2016 between Strata Skin Sciences, Inc. (the "Company"), a Delaware corporation, and Samuel E. Navarro (the "Consultant") effective as of July 1, 2016 (the "Effective Date").

Recitals:

The parties entered into a Consulting Agreement dated as of November 4, 2015 (the "Agreement"), under which the Consultant provided consulting services to the Company.  The Consulting Agreement continued in effect through June 30, 2016.  The parties wish to extend the term of the Agreement through September 30, 2016, as provided in this Amendment.

NOW, THEREFORE, in consideration of the premises and covenants set forth herein, and intending to be legally bound hereby, the parties agree as follows:

IN WITNESS WHEREOF, the parties have caused this Amendment to be executed as of the date first written above.

 

---